Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor κB cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3561-3569

  Lee, Jay M ^a   Mahtabifard, Ali ^a   Yamada, Reiko ^a   Crystal, Ronald G ^b   Korst, Robert J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYTOKINE; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDE; TRANSCRIPTION FACTOR RELA; ADENOVIRUS VECTOR; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN P40; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL;

ADENOVIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; DENDRITIC CELL; FLOW CYTOMETRY; GENE; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MOUSE; PROTEIN TERTIARY STRUCTURE; TIME; UPREGULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC VECTORS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NF-KAPPA B; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036848857     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991
2. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y-J., Pulendran, B., and Palucka, K. Immunobiology of dendritic cells. Annu. Rev. Immunol., 18: 767-811, 2000
3. Banchereau, J., and Steinman, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998
4. Fong, L., and Engleman, E. G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol., 18: 245-273, 2000
5. Ghosh, S., May, M. J., and Kopp, E. B. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16: 225-260, 1998
6. May, M. J., and Ghosh, S. Rel/NF-κB and I-κB proteins: An overview. Semin. Cancer Biol., 8: 63-73, 1997
7. Tak, P. P., and Firestein, G. S. NF-κB: a key role in inflammatory diseases. J. Clin. Investig., 107: 7-11, 2001
8. Lyakh, L. A., Koski, G. K., Telford, W., Gress, R. E., Cohen, P. A., and Rice, N. R. Bacterial lipopolysaccharide. TNF-α, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NF-κB. J. Immunol., 165: 3647-3655, 2000
9. Rescigno, M., Martino, M., Sutherland, C. L., Gold, M. R., and Ricciardi-Castagnoli, P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med., 188: 2175-2180, 1998
10. Clark, G. J., Gunningham, S., Troy, A., Vuckovic, S., and Hart, D. N. J. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology, 98: 189-196, 1999
11. Neumann, M., Fries, H-W., Scheicher, C., Keikavoussi, P., Kolb-Maurer, A., Brocker, E-B., Serfling, E., and Kampgen, E. Differential expression of Rel/NF-κB and octomer factors is a hallmark of the generation and maturation of dendritic cells. Blood, 95: 277-285, 2000
12. Ardeshna, K. M., Pizzey, A. R., Devereux, S., Khwaja, A. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood, 96: 1039-1046, 2000
13. Morelli, A. E., Larregina, A. T., Ganster, R. W., Zahorchak, A. F., Plowey, J. M., Takayama, T., Logar, A., J. Robbins, P. D., Falo, L. D., and Thomson, A. W. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway. J. Virol., 74: 9617-9628, 2000
14. Yoshimura, S., Bondeson, J., Foxwell, B. M. J., Brennan, F. M., and Feldmann, M. Effective antigen presentation by dendritic cells is NF-κB dependent: Coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol., 13: 675-683, 2001
15. Verhasselt, V., Berghe, W. V., Vanderheyde, N., Willems, F., Haegeman, G., and Goldman, M. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-κB inhibition. J. Immunol., 162: 2569-2574, 1999
16. Wulczyn, F. G., Krappmann, D., and Scheidereit, C. The NF-κB/Rel and I-κB gene families: Mediators of immune response and inflammation. J. Mol. Med., 74: 749-769, 1996
17. Gilmore, T. D., Koedood, M., Piffat, K. A., and White, D. W. Rel/NF-κB/I-κB proteins and cancer. Oncogene, 13: 1367-1378, 1996
18. Kurland, J. F., Kodym, R., Story, M. D., Spurgers, K. B., McDonnell, T. J., and Meyn, R. E. NF-κB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J. Biol. Chem., 276: 45380-45386, 2001
19. Vincenti, M. P., Coon, C. I., Brinckerhoff, C. E. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1 β-stimulated synovial fibroblasts. Arthritis Rheum., 41: 1987-1994, 1998
20. Anrather, J., Csizmadia, V., Brostjan, C., Soares, M. P., Bach, F. H., Winkler, H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J. Clin. Investig., 99: 763-772, 1997
21. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med., 176: 1693-1702, 1992
22. Song, W., Kong, H. L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M. A., and Crystal, R. G. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med., 186: 1247-1256, 1997
23. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., Jallat, S., Pavirani, A., Lecocq, J-P., and Crystal, R. G. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science (Wash. DC), 252: 431-434, 1991
24. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L. D., Perricaudet, M., Guggino, W. B., Pavirani, A., Lecocq, J-P., and Crystal, R. G. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell, 68: 143-155, 1992
25. Mittereder, N., March, K. L., and Trapnell, B. C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol., 70: 7498-7509, 1996
26. Soares, M. P., Muniappan, A., Kaczmarek, E., Koziak, K., Wrighton, C. J., Steinhauslin, F., Ferran, C., Winkler, H., Bach, F. H., and Anrather, J. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J. Immunol., 161: 4572-4582, 1998
27. Hersh, J., Crystal, R. G., and Bewig, B. Modulation of gene expression after replication deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther., 2: 124-131, 1995
28. Kikuchi, T., Moore, M. A. S., and Crystal, R. G. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors. Blood, 96: 91-99, 2000
29. Shimonkevitz, R., Colon, S., Kappler, J. W., Marrack, P., and Grey, H. M. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol., 133: 2067-2074, 1984
30. Trinchieri, G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cell type 1 and cytotoxic lymphocytes. Blood, 84: 4008-4027, 1995
31. Mosmann, T. R., and Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today, 17: 138-146, 1996
32. Van Kooten, C., and Banchereau, J. CD40-CD40 ligand. J. Leukoc. Biol., 67: 2-17, 2000
33. Jonuleit, H., Tuting, T., Steitz, J., Bruck, J., Giesecke, A., Steinbrink, K., Knop, J., and Enk, A. H. Efficient transduction of mature CD83 + dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther., 7: 249-254, 2000
34. Sanjabi, S., Hoffman, A., Liou, H-C., Baltimore, D., and Smale, S. T. Selective requirement for c-Rel during IL-12 p40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA, 97: 12705-10, 2000
35. Grumont, R., Hochrein, H., O'Keeffe, M., Gugasyan, R., White, C., Caminschi, I., Cook, W., and Gerondakis, S. c-Rel regulates interleukin 12 p70 expression in CD8+ dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med., 194: 1021-1031, 2001
36. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R., and Lo, D. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (Lond.), 373: 531-536, 1995
37. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.), 376: 167-170, 1995
38. Eggert, A. O., Becker, J. C., Ammon, M., McLellan, A. D., Renner, G., Merkel, A., Broker, E-B., and Kampgen, E. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture. Eur. J. Immunol., 32: 122-127, 2002
39. Stober, D., Schirmbeck, R., and Reimann, J. IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J. Immunol., 167: 957-965, 2001
40. Muller, G., Muller, A., Jonuleit, H., Steinbrink, K., Szalma, C., Paragnik, L., Lingnau, K., Schmidt, E., Knop, J., and Enk, A. H. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J. Investig. Dermatol., 114: 142-148, 2000
41. Labeur, M. S., Roters, B., Pers, B. Mehling, A., Luger, T. A., Schwartz, T., and Grabbe, S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol., 162: 168-175, 1999
42. McArthur, J. G., and Mulligan, R. C. Induction of protective antitumor immunity by gene-modified dendritic cells. J. Immunother., 21: 41-47, 1998
43. Timmerman, J. M., and Levy, R. Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med., 50: 507-529, 1999